🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This is an open-label, multicentre, dose escalation study to characterize t...
Status
Completed
Location
AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I
Start Date
2011-07
Trial ID
NCT01421186
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of mosu...
Status
Active Not Recruiting
Location
Infirmary Cancer Care
Start Date
2022-02-01
Trial ID
NCT05207670
Treatments Being Tested
This phase II clinical trial evaluates whether a modified modality of condi...
Status
Recruiting
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2021-10-25
Trial ID
NCT05031897
Background: The myelodysplastic syndromes (MDS) are a group of bone marrow...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2022-11-29
Trial ID
NCT05148234
This phase Ib/II trial studies the side effects and best dose of pinometost...
Status
Terminated
Location
Yale University
Start Date
2019-04-10
Trial ID
NCT03724084
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested
The primary objective of this study is to evaluate the safety, tolerability...
Status
Terminated
Location
Stanford Hospital and Clinics
Start Date
2015-06-05
Trial ID
NCT02436135
Treatments Being Tested